| Basics |
Novo-Nordisk A/S
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.
|
| IPO Date: |
April 1, 1981 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$323.61B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.58 | 0.72%
|
| Avg Daily Range (30 D): |
$0.99 | 1.47%
|
| Avg Daily Range (90 D): |
$1.02 | 1.43%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.19M |
| Avg Daily Volume (30 D): |
10.08M |
| Avg Daily Volume (90 D): |
8.91M |
| Trade Size |
| Avg Trade Size (Sh.): |
101 |
| Avg Trade Size (Sh.) (30 D): |
93 |
| Avg Trade Size (Sh.) (90 D): |
89 |
| Institutional Trades |
| Total Inst.Trades: |
21,460 |
| Avg Inst. Trade: |
$4.44M |
| Avg Inst. Trade (30 D): |
$4.06M |
| Avg Inst. Trade (90 D): |
$4.55M |
| Avg Inst. Trade Volume: |
.14M |
| Avg Inst. Trades (Per Day): |
5 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.7M |
| Avg Closing Trade (30 D): |
$18.74M |
| Avg Closing Trade (90 D): |
$19.37M |
| Avg Closing Volume: |
86.95K |
|
|
| Splits |
|
Sep 20, 2023:
2:1
|
|
Jan 09, 2014:
5:1
|
|
Dec 17, 2007:
2:1
|
|
Apr 11, 2001:
5:2
|
|
|
|
